Atopic dermatitis as a systemic disease

Clinics in Dermatology

Volumn 32, Issue 3, 2014, Pages 409-413

  Darlenski, Razvigor ^a   Kazandjieva, Jana ^a   Hristakieva, Evgeniya ^b   Fluhr, Joachim W ^c  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANXIETY; ASTHMA; ATOPIC DERMATITIS; ATOPY; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CYSTIC FIBROSIS; DEPRESSION; DISEASE ASSOCIATION; DOWN SYNDROME; DRUG HYPERSENSITIVITY; ENDOMETRIOSIS; EOSINOPHILIC GASTROENTERITIS; HEARING IMPAIRMENT; HUMAN; HYPERLIPIDEMIA; HYPOPROTEINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; LANGERHANS CELL; LIPOPROTEIN BLOOD LEVEL; MULTIPLE SCLEROSIS; NEPHRITIS; NOTE; OBESITY; PATHOPHYSIOLOGY; POISONOUS INSECT; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RHINOCONJUNCTIVITIS; RISK FACTOR; SCHIZOPHRENIA; SKIN WATER LOSS; STRATUM CORNEUM; VERNAL CONJUNCTIVITIS; AUTOIMMUNE DISEASE; COMPLICATION; DISEASE COURSE; EPIDERMIS; EYE DISEASE; GASTROINTESTINAL DISEASE; IMMUNOLOGY; KIDNEY DISEASE; METABOLIC SYNDROME X; PSYCHOLOGY;

AUTOIMMUNE DISEASES; DERMATITIS, ATOPIC; DISEASE PROGRESSION; EPIDERMIS; EYE DISEASES; GASTROINTESTINAL DISEASES; HUMANS; KIDNEY DISEASES; METABOLIC SYNDROME X;

EID: 84899058787     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2013.11.007     Document Type: Note

References (49)

1. Gupta M.A., Gupta A.K. Sleep-wake disorders and dermatology. Clin Dermatol 2013, 31:118-126.
2. Wollenberg A., Ehmann L.M. Long term treatment concepts and proactive therapy for atopic eczema. Ann Dermatol 2012, 24:253-260.
3. Plotz S.G., Ring J. What's new in atopic eczema?. Expert Opin Emerg Drugs 2010, 15:249-267.
4. Tar̈ieb A., Wallach D., Tilles G. The history of atopic eczema/dermatitis. Handbook of Atopic Eczema 2006, 10-20. Springer, Berlin, Heidelberg. J. Ring, B. Przybilla, T. Ruzicka (Eds.).
5. Mier P.D. Earliest description of the atopic syndrome?. Br J Dermatol 1975, 92:359.
6. Coca A.F., Cooke R.A. On classification of the phenomena of hypersensitiveness. J Immunol 1923, 8:163-182.
7. Morar N., Willis-Owen S.A., Moffatt M.F., et al. The genetics of atopic dermatitis. J Allergy Clin Immunol 2006, 118:24-34. [quiz 5-6].
8. Bieber T., Novak N. Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 2009, 9:291-294.
9. Bieber T., de la Salle H., Wollenberg A., et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992, 175:1285-1290.
10. Leung D.Y., Boguniewicz M., Howell M.D., et al. New insights into atopic dermatitis. J Clin Invest 2004, 113:651-657.
11. Kim Y.H., Park C.S., Jang T.Y. Immunologic properties and clinical features of local allergic rhinitis. J Otolaryngol Head Neck Surg 2012, 41:51-57.
12. Proksch E., Folster-Holst R., Jensen J.M. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006, 43:159-169.
13. Darlenski R., Fluhr J.W. Influence of skin type, race, sex, and anatomic location on epidermal barrier function. Clin Dermatol 2012, 30:269-273.
14. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
15. Basu K., Palmer C.N., Lipworth B.J., et al. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 2008, 63:1211-1217.
16. Novak N., Baurecht H., Schafer T., et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008, 128:1430-1435.
17. Schuttelaar M.L., Kerkhof M., Jonkman M.F., et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 2009, 64:1758-1765.
18. Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009;123:1361-1370 e7.
19. Hogan M.B., Peele K., Wilson N.W. Skin barrier function and its importance at the start of the atopic march. J Allergy (Cairo) 2012, 2012:901-940.
20. De Smedt S., Wildner G., Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophthalmol 2013, 97:9-14.
21. Bawazeer A.M., Hodge W.G., Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 2000, 84:834-836.
22. Bair B., Dodd J., Heidelberg K., et al. Cataracts in atopic dermatitis: a case presentation and review of the literature. Arch Dermatol 2011, 147:585-588.
23. Khan S, Orenstein SR. Eosinophilic gastroenteritis. Gastroenterol Clin North Am. 2008;37:333-348, v.
24. Tzanakis N.E., Tsiligianni I.G., Siafakas N.M. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010, 16:299-305.
25. Niwa Y., Sumi H., Akamatsu H. An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers. J Invest Dermatol 2004, 123:999-1000.
26. Salsano M.E., Graziano L., Luongo I., et al. Atopy in childhood idiopathic nephrotic syndrome. Acta Paediatr 2007, 96:561-566.
27. Cheung W., Wei C.L., Seah C.C., et al. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol 2004, 19:627-632.
28. Yap H.K., Yip W.C., Lee B.W., et al. The incidence of atopy in steroid-responsive nephrotic syndrome: clinical and immunological parameters. Ann Allergy 1983, 51:590-594.
29. Kokkonen J., Niinimaki A. Increased incidence of autoimmune disorders as a late complication in children with early onset dermatitis and/or milk allergy. J Autoimmun 2004, 22:341-344.
30. Pedulla M., Miraglia Del Giudice M., Fierro V., et al. Atopy as a risk factor for thyroid autoimmunity in children. J Biol Regul Homeost Agents 2012, 26:S9-S14.
31. Rabin R.L., Levinson A.I. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol 2008, 153:19-30.
32. Mittermann I., Aichberger K.J., Bunder R., et al. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004, 4:367-371.
33. Ma J., Xiao L., Knowles S.B. Obesity, insulin resistance and the prevalence of atopy and asthma in US adults. Allergy 2010, 65:1455-1463.
34. Sismanopoulos N., Delivanis D.A., Mavrommati D., et al. Do mast cells link obesity and asthma?. Allergy 2013, 68:8-15.
35. Pike K.C., Inskip H.M., Robinson S.M., et al. The relationship between maternal adiposity and infant weight gain, and childhood wheeze and atopy. Thorax 2013, 68:372-379.
36. Kusunoki T., Morimoto T., Sakuma M., et al. Total and low-density lipoprotein cholesterol levels are associated with atopy in schoolchildren. J Pediatr 2011, 158:334-336.
37. Chernyshov P.V. Gender differences in health-related and family quality of life in young children with atopic dermatitis. Int J Dermatol 2012, 51:290-294.
38. Misery L., Finlay A.Y., Martin N., et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology 2007, 215:123-129.
39. White A., Horne D.J., Varigos G.A. Psychological profile of the atopic eczema patient. Australas J Dermatol 1990, 31:13-16.
40. Gieler U., Ehlers A., Höhler T., et al. Die psychosoziale Situation der Patientenmit endogenem Ekzem. Hautarzt 1990, 41:416-423.
41. Takahashi H., Tsuji H., Honma M., et al. Japanese patients with psoriasis and atopic dermatitis show distinct personality profiles. J Dermatol 2013, 40:370-373.
42. Slattery M.J., Essex M.J. Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents. J Psychiatr Res 2011, 45:788-795.
43. Yaghmaie P., Koudelka C.W., Simpson E.L. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013, 131:428-433.
44. Cicek D., Halisdemir N., Dertioglu S.B., et al. Increased frequency of restless legs syndrome in atopic dermatitis. Clin Exp Dermatol 2012, 37:469-476.
45. Pedersen M.S., Benros M.E., Agerbo E., et al. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res 2012, 138:58-62.
46. Saint-Mezard P., Chavagnac C., Bosset S., et al. Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 2003, 171:4073-4080.
47. Choi E.H., Brown B.E., Crumrine D., et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005, 124:587-595.
48. Vieluf D., Rieker J., Ruzicka T. Complications and diseases associated with atopic eczema. Handbook of Atopic Eczema 2006, 115-143. Springer, Berlin, Heidelberg. J. Ring, B. Przybilla, T. Ruzicka (Eds.).
49. Darlenski R.B., Neykov N.V., Vlahov V.D., et al. Evidence-based medicine: facts and controversies. Clin Dermatol 2010, 28:553-557.